Home › Biogen and Sobi Announce European Medicines Agency Validates...
 

Keywords :   


Biogen and Sobi Announce European Medicines Agency Validates...

2015-06-26 10:44:02| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has accepted the Marketing Authorization Application of ALPROLIX A , a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA's review process.

Tags: agency european announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
27.09Starmer says Tesla investment welcome after Musk row
27.09Microsoft re-launches privacy nightmare AI screenshot tool
27.09Titanic shipbuilder formally enters administration
27.09Warner Bros. Discovery deploys captioning using Google Cloud AI
27.09Cignal TV expands service to Android set-tops with Quickplay
27.09Comcast to deploy Qwilt Open Edge CDN platform
27.09Liberty Broadband makes counterproposal to Charter merger offer
27.09Livepeer Studio can reduce the cost of real-time streaming by 74%
Consumer Goods and Services »
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »